Mounjaro (Tirzepatide) Injection 15mg

Additional Information

Product Name	Mounjaro (Tirzepatide) Injection 15mg
Brand	Eli Lilly and Company
Dosage	15 mg / 0.5 mL — subcutaneous injection, once weekly
Description	Mounjaro (tirzepatide) 15mg is the maximum approved dose of this dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients (10 years and older) with type 2 diabetes mellitus, and for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Clinical trials demonstrated average weight loss of 8.8 to 12.9 kg at the 15mg dose — the highest weight reduction among all Mounjaro doses. Administered as a once-weekly subcutaneous injection.
Special Ingredients
Ingredients (All)
Categories	GLP-1 Support & Weight Management
Disclaimer
Longevity Health Co. does not provide medical advice. Customers are advised to consult a licensed healthcare professional before starting any supplement or prescription medication. Products requiring medical supervision should only be used under the guidance of a qualified healthcare professional.